Expanding and transferring regulatory T cells to enhance immune tolerance
17 Jun 2025
Immune Regulation
Autologous vs allogeneic Treg cell therapies - which one first and why?
- Discuss pros/cons of each one in the context of chronic vs acute diseases
Natural Foxp3+ CD4 Tregs vs induced or forced-expressed Foxp3+ CD4 Tregs vs Tr1 Tregs.
- Comparative analysis with difference/pros/cons, MOA or indication
Navigating specificity, avidity and HLA-restriction to fine-tune TCR Treg cell therapy
-
Polyclonal vs ag-specific strategies and their limitations